Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04469946 · ClinicalTrials.gov registry record · NA

Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)

A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT04469946 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04469946, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. The study used a within-subjects design with pre- and post-comparisons involving fifteen pediatric (ages 6-12) patients with symmetrical sensorineural hearing losses ranging from the mild to moderately-severe degree. All participants were fit with bilateral Oticon OPN™ behind-the-ear hearing aids set with the OSN algorithm enabled. The investigators evaluated hearing aid benefit through word recognition in noise (behavioral testing) and everyday hearing/listening abilities (parental/legal guardian reported) within one week of the hearing aid fitting (pre-intervention) and two months post fitting (post-intervention).

Interventions

  • DEVICE Oticon OpenSound Navigator speech enhancement algorithm

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-03-05
Est. Completion 2018-09-30
Phase NA

What the Registry Record Tells You About NCT04469946

The ClinicalTrials.gov registry entry for NCT04469946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Oticon OpenSound Navigator speech enhancement algorithm is the first listed.

NCT04469946 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04469946 about?

NCT04469946 is a clinical study titled "Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)". The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. The study used a within-subjects design with pre- and post-comparisons involving fifteen pediatric (ages 6...

What is the current status of trial NCT04469946?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-03-05. Estimated completion is 2018-09-30.

What interventions are being tested in trial NCT04469946?

The interventions under investigation include: Oticon OpenSound Navigator speech enhancement algorithm (DEVICE).

Who is sponsoring clinical trial NCT04469946?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.